The firms will evaluate two adjuvant treatment options, Datroway with rilvegostomig or rilvegostomig monotherapy, against standard-of-care treatment.

Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine Approval would give Japan a home-grown mRNA vaccine of the type that has made up the bulk of its COVID inoculations so far.

Daiichi Sankyo has made a little bit of pharma industry ... virus that selectively kills malignant cells. Japan's Ministry of Health, Labour and Welfare (MHLW) has granted a conditional approval ...

Just 11 days after AstraZeneca and Daiichi Sankyo gained FDA approval for their ... M.D., trial investigator and UCLA Health Jonsson Comprehensive Cancer Center, said in a release.

Even before the FDA's recent approval of Dato-DXd in breast cancer, analysts predicted sales of the antibody-drug conjugate ...

The U.S. Food and Drug Administration has approved AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) ENHERTU ...

Japan's health ministry said on Friday it agreed to buy 1.4 million doses of Daiichi Sankyo's updated COVID-19 vaccine. The purchase is contingent on approval of the shot formulated for the XBB.1. ...

(RTTNews) - The U.S. Food and Drug Administration approved AstraZeneca (AZN, AZN.L) and Daiichi Sankyo's (DSKYF.PK ... For More Such Health News, visit rttnews.com. The views and opinions ...

(AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK ... Monday's Regular trading at $70.08 up $1.02 or 1.48%. For More Such Health News, visit rttnews.com. The views and opinions expressed herein are ...